At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 20 target
Drug / intervention
Endovascular autologous mitochondrial transplantationother
Likely dose
Not stated in record
Key inclusion· 3
- ✓Eligible for endovascular thrombectomy to treat acute large vessel occlusion
- ✓Eligible for angioplasty to treat acute cerebral vasospasm after aneurysmal subarachnoid hemorrhage
- ✓Sufficient time to obtain meaningful consent from patient or legally-authorized representative
Key exclusion· 3
- ✕Unable to receive a brain MRI scan
- ✕Known mitochondrial disease
- ✕Hemodynamically unstable patients in whom standard of care endovascular reperfusion treatment cannot safely be performed or completed
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NCT04998357N/ARecruitingMonitorUpdated 13mo ago · Completion was 2mo agoSlow Enrollment
Long Recruiting
Monitor
Study Title: Autologous Mitochondrial Transplant for Cerebral Ischemia
In Brief
A clinical study evaluating Endovascular autologous mitochondrial transplantation for Cerebral Ischemia. Currently recruiting, targeting 20 participants across 1 site.
Signals
Enrolling slower than its timeline implies
Detailed Summary
The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Ischemia
CountriesUnited States
Collaborators--
Timeline
N/ARecruiting
20222023202420252026
Enrollment StartApr 2021
First PostedAug 2021
Primary CompletionApr 2026
TodayJul 2026
Study CompletionOct 2026
First PostedAug 10, 2021
Enrollment StartApr 29, 2021
Primary CompletionApr 29, 2026
Study CompletionOct 29, 2026
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 4.9 years ago
Interventions
Endovascular autologous mitochondrial transplantationother
During standard-of-care endovascular reperfusion procedure, subjects will have autologous mitochondria infused via microcatheter into ischemic brain.